Fulgent Genetics Inc
NASDAQ:FLGT
Fulgent Genetics Inc
NASDAQ:FLGT
Price:
20.58 USD
2.39%
Market Closed
Updated:
Apr 30, 2024
Fulgent Genetics Inc
Cash from Financing Activities
|
Fulgent Genetics Inc
Cash from Financing Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Cash from Financing Activities
-$47.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
$2.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$4.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is Fulgent Genetics Inc's Cash from Financing Activities?
Cash from Financing Activities
-47.8m
USD
-47.8m
USD
Based on the financial report for Dec 31, 2023, Fulgent Genetics Inc's Cash from Financing Activities amounts to -47.8m USD.
What is Fulgent Genetics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
38%
38%
Over the last year, the Cash from Financing Activities growth was 38%.
You don't have any saved screeners yet
